Cardiovasc Diabetol

From Bioblast
Jump to: navigation, search
Journals in Bioblast
Journal title and website Cardiovascular Diabetology

Publications

 ViewReferencePublished
Shao 2019 Cardiovasc DiabetolPMID: 31779619 Open AccessShao Q, Meng L, Lee S, Tse G, Gong M, Zhang Z, Zhao J, Zhao Y, Li G, Liu T (2019) Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induce diabetic rats. Cardiovasc Diabetol 18:165.2019
Zhang 2018 Cardiovasc DiabetolPMID: 30591063 Open AccessZhang X, Zhang Z, Yang Y, Suo Y, Liu R, Qiu J, Zhao Y, Jiang N, Liu C, Tse G, Li G, Liu T (2018) Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits. Cardiovasc Diabetol 17:160.2018
Hughey 2013 Cardiovasc DiabetolPMID: 24007410 Open AccessHughey CC, Ma L, James FD, Bracy DP, Wang Z, Wasserman DH, Rottman JN, Hittel DS, Shearer J (2013) Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Cardiovasc Diabetol 12:128.2013